China Biomaterials Market Size & Outlook, 2023-2030
China biomaterials market, 2018-2030 (US$M)
Related Markets
China biomaterials market highlights
- The China biomaterials market generated a revenue of USD 9,122.3 million in 2023 and is expected to reach USD 25,374.1 million by 2030.
- The China market is expected to grow at a CAGR of 15.7% from 2024 to 2030.
- In terms of segment, metallic was the largest revenue generating product in 2023.
- Natural is the most lucrative product segment registering the fastest growth during the forecast period.
Biomaterials market data book summary
| Market revenue in 2023 | USD 9,122.3 million |
| Market revenue in 2030 | USD 25,374.1 million |
| Growth rate | 15.7% (CAGR from 2023 to 2030) |
| Largest segment | Metallic |
| Fastest growing segment | Natural |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Polymers, Natural, Ceramics, Metallic |
| Key market players worldwide | Medtronic PLC, Evonik Industries AG, Carpenter Technology Corp, GNI Group Ltd, Invibio, Zimmer Biomet Holdings Inc, Basf SE, Covalon Technologies Ltd, Stryker Corp, Johnson & Johnson, Dentsply Sirona Inc, Corbion NV, CoorsTek |
Other key industry trends
- In terms of revenue, China accounted for 5.1% of the global biomaterials market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Japan biomaterials market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 28,927.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Biomaterials Market Scope
Biomaterials Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
China biomaterials market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biomaterials market will help companies and investors design strategic landscapes.
Metallic was the largest segment with a revenue share of 40.02% in 2023. Horizon Databook has segmented the China biomaterials market based on polymers, natural, ceramics, metallic covering the revenue growth of each sub-segment from 2018 to 2030.
The Chinese biomaterials market is fragmented with local players that collectively dominate every subsegment. Local players control more than half of the total market, with foreign players holding the remaining, which is mainly due to lower price points and significant financial & regulatory backing from the government.
Two notable foreign players in China are Weigao Group from China and Evonik Industries from Germany, whose products have leading positions in the overall biomaterials market. Other companies present in the market are DePuy Synthes, Genzyme, and Hangzhou Gallop.
Reasons to subscribe to China biomaterials market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of China biomaterials market databook
-
Our clientele includes a mix of biomaterials market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the China biomaterials market , including forecasts for subscribers. This country databook contains high-level insights into China biomaterials market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
China biomaterials market size, by product, 2018-2030 (US$M)
China Biomaterials Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
